Lifecore BiomedicalLFCR -2.11%55 Days Inventory is 139.43 as of Mar. 2026, which is 13% below its 10-year median of 159.81. GuruFocus rates LFCR with a GF Score™ of 55/100 and a GF Value™ of $6.52 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 916 Drug Manufacturers companies, Lifecore Biomedical ranks worse than 53.93% on this metric.
The historical rank and industry rank for Lifecore Biomedical's Days Inventory or its related term are showing as below:
LFCR'
s Days Inventory Range Over the Past 10 Years
Min: 22.5 Med: 159.81 Max: 381.24
Current: 174.45
During the past 13 years, Lifecore Biomedical's highest Days Inventory was 381.24. The lowest was 22.50. And the median was 159.81.
LFCR's Days Inventory is ranked worse than 53.93% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs LFCR: 174.45
Lifecore Biomedical's Days Inventory
increased
from Feb. 2025 (133.06) to Mar. 2026 (139.43).
It might indicate that Lifecore Biomedical's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Lifecore Biomedical's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.65.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lifecore Biomedical's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.23.
Lifecore Biomedical (NAS:LFCR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Lifecore Biomedical's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Lifecore Biomedical's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Lifecore Biomedical Days Inventory Related Terms
Lifecore Biomedical Days Inventory Historical Data
* Premium members only.
The historical data trend for Lifecore Biomedical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFCR vs ANIK, DERM, ASRT: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecore Biomedical Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Lifecore Biomedical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecore Biomedical (LFCR) has a Days Inventory of 139.43 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lifecore Biomedical and its competitors. This is 13% below median its historical median of 159.81. Over the past decade, Lifecore Biomedical's Days Inventory has ranged from 22.50 to 381.24. According to the industry distribution chart, Lifecore Biomedical ranks #494 out of 916 companies in the Drug Manufacturers industry, placing it in the top 53.9%.
Is Lifecore Biomedical's Days Inventory too high?
Lifecore Biomedical's current Days Inventory of 139.43 is 13% below median its 10-year median of 159.81. Over the past 10 years, this metric has ranged from a low of 22.50 to a high of 381.24. The Drug Manufacturers industry median Days Inventory is 164.43. Lifecore Biomedical's value of 139.43 is 15.2% below this industry median. Based on the distribution chart, Lifecore Biomedical ranks #494 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Lifecore Biomedical has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lifecore Biomedical's Days Inventory compare to ANIK and DERM?
According to the Drug Manufacturers industry distribution chart, Lifecore Biomedical ranks #494 out of 916 companies for Days Inventory. This places Lifecore Biomedical in the lower half of its industry. The industry median Days Inventory is 164.43. Lifecore Biomedical's value of 139.43 is 15.2% below this benchmark. Historically, Lifecore Biomedical's own Days Inventory has ranged from 22.50 to 381.24 over the past decade. While the company's 10-year median is 159.81 vs. the industry median of 164.43, Lifecore Biomedical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lifecore Biomedical's current Days Inventory of 139.43 is 15.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Lifecore Biomedical and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecore Biomedical's current Days Inventory is 139.43, which is 13% below median its own 10-year median of 159.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecore Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Lifecore Biomedical (LFCR) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.52, compared to a current price of $4.87 — trading 25.4% below its estimated fair value. The current Days Inventory is 139.43, which is 13% below median its 10-year median of 159.81 and 15.2% below the Drug Manufacturers industry median of 164.43. Lifecore Biomedical's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Lifecore Biomedical (LFCR), the current Days Inventory is 139.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecore Biomedical (LFCR) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued.
The current stock price of $4.87 is trading 25.4% below its estimated GF Value™ of $6.52.
GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.
Key valuation signals for LFCR:
Days Inventory: 139.43 (13% below median its 10-year median of 159.81)
GF Value™: $6.52 vs. price of $4.87 (25.4% below fair value)
Industry Position: 15.2% below the Drug Manufacturers median (#494 of 916)
No single metric tells the full story. See the LFCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
55GF Score
Get the complete analysis for LFCR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFCR has been successfully added to your 
